Enovis Corporation
NYSE:ENOVMedical - Devices
+$0.73 today
- Market cap
- $1.56B
- Beta
- 1.49
- P/E (TTM)
- -1.1
- EPS (TTM)
- -$20.02
Volume 0.88M
Average 0.99M
Returns on capital
Enovis Corporation management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-79.5%
avg -9.7%
ROIC
-0.6%
avg -0.9%
ROA
-30.9%
avg -4.2%
Analysis
ROIC is currently the strongest return metric at -0.6% versus its period average of -0.9%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Damien McDonald | Chief Executive Officer & Director | USD 2.34M | 61 | 247.08K | 0.43% |
Phillip Benjamin Berry | Senior Vice President & Chief Financial Officer | USD 1.11M | 47 | — | — |
Terry Ross | Group President Prevention & Recovery | USD 969.4K | 56 | — | — |
Patricia A. Lang | Advisor | USD 928.84K | 67 | 75.70K | 0.13% |
Laura Singleton | Senior Vice President & Chief Human Resources Officer | USD 896.34K | — | — | — |
Bradley J. Tandy | Senior Vice President & Chief Legal Officer | USD 874.35K | 67 | 65.64K | 0.11% |
Louie Vogt | Group President of Reconstructive | USD 867.13K | 45 | — | — |
Oliver Engert | Chief Administrative Officer | — | 61 | 63.90K | 0.11% |
John Kleckner | Vice President, Controller & Chief Accounting Officer | — | 49 | 25.88K | 0.04% |
Kyle William Rose | Vice President of Investor Relations | — | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Sep 4, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
24
$912,373.72
Sells
4
$45,297.99
Net Transaction Value
+$867,075.73
Net buying
Most Active
Engert Oliver
16 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Nov 11, 26Nov 11, 2026 | Wienbar Sharon L Direct | Buy | $25K$24,984.00 |
| Nov 11, 26Nov 11, 2026 | Lalor Angela S Direct | Buy | $25.1K$25,108.20 |
| Nov 10, 26Nov 10, 2026 | Wienbar Sharon L Direct | Buy | $24.8K$24,847.82 |
| Nov 10, 26Nov 10, 2026 | Lalor Angela S Direct | Buy | $25.1K$25,084.36 |
| Nov 9, 26Nov 9, 2026 | Wienbar Sharon L Direct | Buy | $24.9K$24,929.52 |
| Nov 6, 26Nov 6, 2026 | Wienbar Sharon L Direct | Buy | $25K$24,987.85 |
| Sep 4, 26Sep 4, 2026 | Engert Oliver Direct | Buy | $50K$50,008.00 |
| Sep 4, 26Sep 4, 2026 | McDonald Damien Direct | Buy | $249.6K$249,620.25 |
| Sep 3, 26Sep 3, 2026 | Engert Oliver Direct | Buy | $100K$100,024.40 |
| Sep 2, 26Sep 2, 2026 | Engert Oliver Direct | Buy | $49.9K$49,946.56 |
1–10 of 28
Summary
Insiders reported 24 buys worth $912,373.72 and 4 sells worth $45,297.99 over the last 12 months. That adds up to net buying of $867,075.73. Engert Oliver was the most active insider with 16 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +12.9% | +5.1% (4yr)6 analysts |
| Net Income | N/A | N/A | N/A | N/A6 analysts |
| EBIT | N/A | N/A | N/A | N/A6 analysts |
Analysis
Recent growth has been strongest in Revenue at +12.9% over three years. Forward estimates point to Revenue at +5.1% (4yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does Enovis Corporation compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
ITT Inc.
NYSE:ITT
Market cap
$18.84B
IDEX Corporation
NYSE:IEX
Market cap
$17.45B
Watts Water Technologies, Inc.
NYSE:WTS
Market cap
$12.03B
Donaldson Company, Inc.
NYSE:DCI
Market cap
$10.04B
The Middleby Corporation
NASDAQ:MIDD
Market cap
$6.11B
EnPro Industries, Inc.
NYSE:NPO
Market cap
$5.79B
Franklin Electric Co., Inc.
NASDAQ:FELE
Market cap
$4.34B
Kadant Inc.
NYSE:KAI
Market cap
$3.47B
Enerpac Tool Group Corp.
NYSE:EPAC
Market cap
$2.02B
The Gorman-Rupp Company
NYSE:GRC
Market cap
$1.84B
Helios Technologies, Inc.
NYSE:HLIO
Market cap
$1.53B
Graham Corporation
NYSE:GHM
Market cap
$979.18M
Luxfer Holdings PLC
NYSE:LXFR
Market cap
$464.01M
Omega Flex, Inc.
NASDAQ:OFLX
Market cap
$236.61M
Hurco Companies, Inc.
NASDAQ:HURC
Market cap
$131.92M
Questions
Management questions
Common questions about ENOV's management, answered from reported figures.
Who manages ENOV?
Enovis Corporation (ENOV) lists 10 active executives. The top listed executive is Patricia A. Lang, Advisor.
Are ENOV insiders buying or selling?
Recent insider activity shows net selling of $7.85M.
Continue the stock analysis
Jump to another research area for this company.